NO954325L - Systemer for kontrollert frigivning av pilokaprin - Google Patents

Systemer for kontrollert frigivning av pilokaprin

Info

Publication number
NO954325L
NO954325L NO954325A NO954325A NO954325L NO 954325 L NO954325 L NO 954325L NO 954325 A NO954325 A NO 954325A NO 954325 A NO954325 A NO 954325A NO 954325 L NO954325 L NO 954325L
Authority
NO
Norway
Prior art keywords
pilocaprine
controlled release
release systems
systems
controlled
Prior art date
Application number
NO954325A
Other languages
English (en)
Other versions
NO954325D0 (no
NO309174B1 (no
Inventor
Lothar Deurer
Karlheinz Otto
Thomas Hille
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO954325D0 publication Critical patent/NO954325D0/no
Publication of NO954325L publication Critical patent/NO954325L/no
Publication of NO309174B1 publication Critical patent/NO309174B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO954325A 1993-04-28 1995-10-27 Anvendelse av pilokarpin eller et av dets farmasöytisk akseptable salter for fremstilling av et transdermalt terapeutisk system NO309174B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4313928A DE4313928C2 (de) 1993-04-28 1993-04-28 Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
PCT/EP1994/001281 WO1994025025A2 (de) 1993-04-28 1994-04-25 Systeme zur kontrollierten abgabe von pilocarpin

Publications (3)

Publication Number Publication Date
NO954325D0 NO954325D0 (no) 1995-10-27
NO954325L true NO954325L (no) 1995-10-30
NO309174B1 NO309174B1 (no) 2000-12-27

Family

ID=6486612

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954325A NO309174B1 (no) 1993-04-28 1995-10-27 Anvendelse av pilokarpin eller et av dets farmasöytisk akseptable salter for fremstilling av et transdermalt terapeutisk system

Country Status (19)

Country Link
US (1) US5869086A (no)
EP (1) EP0695182A1 (no)
JP (1) JPH08509716A (no)
KR (1) KR960702308A (no)
AU (1) AU694115B2 (no)
CA (1) CA2161520A1 (no)
CZ (1) CZ277995A3 (no)
DE (1) DE4313928C2 (no)
FI (1) FI955161A (no)
HR (1) HRP940270A2 (no)
HU (1) HU220045B (no)
IL (1) IL109340A (no)
NO (1) NO309174B1 (no)
NZ (1) NZ265950A (no)
PL (1) PL175077B1 (no)
SK (1) SK134395A3 (no)
WO (1) WO1994025025A2 (no)
YU (1) YU22894A (no)
ZA (1) ZA942874B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU719171B2 (en) * 1995-01-14 2000-05-04 Abbott Laboratories A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung
EP1221315A4 (en) * 1999-10-13 2007-12-12 Senju Pharma Co ADHESIVE OPHTHALMIC PREPARATIONS FOR PERCUTANEOUS SPREADING
DE10246503A1 (de) * 2002-03-26 2003-10-16 Tesa Ag Verwendung von Haftklebemassen für medizinische Verklebungen
EP1591110B1 (en) * 2003-01-22 2015-03-18 Senju Pharmaceutical Co., Ltd. Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
CN1819846A (zh) * 2004-05-21 2006-08-16 千寿制药株式会社 包含毒蕈碱性受体激动剂的经皮肤吸收的眼用制剂
CA2597525A1 (en) * 2005-02-17 2006-08-24 Senju Pharmaceutical Co., Ltd. Solid ophthalmic drug for external use
US20090082381A1 (en) * 2005-07-26 2009-03-26 Akiharu Isowaki Percutaneously Absorbable Ophthalmic Preparation
US20100323978A1 (en) * 2009-06-22 2010-12-23 Calvin Hanna Non-aqueous oil delivery system for ophthalmic drugs
EP2606895A4 (en) * 2010-10-12 2014-04-02 Univ Wuhan TRANSDERMAL ABSORPTION STAMP OF ANTIVIRAL DRUG AND METHOD FOR PREPARING THE SAME
KR101688061B1 (ko) 2014-10-06 2017-01-02 주식회사한국파마 필로카르핀 경피 흡수 제제
JP6526475B2 (ja) * 2015-04-30 2019-06-05 サンスター株式会社 経皮唾液腺投与用の唾液分泌促進剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3760805A (en) * 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US3987790A (en) * 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4713244A (en) * 1985-08-16 1987-12-15 Bausch & Lomb Incorporated Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
CA1295941C (en) * 1985-08-16 1992-02-18 Rajan Bawa Sustained-release formulation comprising a hydrophobic polymer system
US4931279A (en) * 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
US5273757A (en) * 1987-09-01 1993-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Apparatus for the delivery of substances, processes for the production thereof and use thereof
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5021053A (en) * 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
EP0523150A4 (en) * 1990-04-06 1993-09-29 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
ATE167800T1 (de) * 1990-04-27 1998-07-15 Allergan Inc Polymeres arzneimittelabgabesystem

Also Published As

Publication number Publication date
US5869086A (en) 1999-02-09
DE4313928A1 (de) 1994-11-03
CZ277995A3 (en) 1996-05-15
HUT75029A (en) 1997-03-28
AU694115B2 (en) 1998-07-16
SK134395A3 (en) 1997-02-05
FI955161A (fi) 1995-11-24
PL311281A1 (en) 1996-02-05
CA2161520A1 (en) 1994-11-10
ZA942874B (en) 1995-07-06
FI955161A0 (fi) 1995-10-27
HU220045B (hu) 2001-10-28
DE4313928C2 (de) 1996-09-19
HU9503087D0 (en) 1995-12-28
IL109340A0 (en) 1994-07-31
NZ265950A (en) 1997-08-22
KR960702308A (ko) 1996-04-27
HRP940270A2 (en) 1996-08-31
NO954325D0 (no) 1995-10-27
JPH08509716A (ja) 1996-10-15
IL109340A (en) 1998-10-30
YU22894A (sh) 1997-08-22
WO1994025025A3 (de) 1995-03-02
EP0695182A1 (de) 1996-02-07
NO309174B1 (no) 2000-12-27
WO1994025025A2 (de) 1994-11-10
AU6648194A (en) 1994-11-21
PL175077B1 (pl) 1998-10-30

Similar Documents

Publication Publication Date Title
ATE214729T1 (de) Freisetzungssysteme
DE69309173D1 (de) Bremssysteme
DE69307057D1 (de) Bremsanlagen
DE59404568D1 (de) Beschichtungsanlage
FI20030560A (fi) Hallitusti vapauttava valmiste
NO932649D0 (no) Kjoeretoey-lokaliseringssystem
DE69311359T2 (de) Befehlssystem
DE69328393D1 (de) Bremssteuerungssystem
KR950702101A (ko) 항부정맥제의 방출 제어를 위한 시스템(System for controlled release of antiarrhythmic agents)
FI930233A0 (fi) System foer bekaempning av braender
DE69301304D1 (de) Kupplungssteuerungssystem
FI931121A0 (fi) Bockningspress foer framstaellning av boejda glasrutor
NO954325D0 (no) Systemer for kontrollert frigivning av pilokaprin
DE69224731T2 (de) Anfangsphasen-Kupplungssteuerungssystem
FI973107A (fi) Hallitusti vapautuvat vesiympäristön ravintoaineet
DE59302610D1 (de) Bremssystem
AU5702194A (en) Tablets for the controlled release of 4-asa
DE69228830T2 (de) Mikroskopsystem
NO942935D0 (no) System for styring av slagg
FI930710A (fi) Anordning foer oevervakning av vaetskenivao
FI932090A0 (fi) Foerfarande foer bestaemning av hisskorgens laege i hisschaktet
FI933708A0 (fi) System saerskilt foer registrering av elektromagnetiska lagringar
KR970000111U (ko) 도계 설비 시스템의 3차 이양기
FI934756A0 (fi) Anordning foer avlaegsnande av utstansade delar
FI922005A (fi) Logistiskt system foer utnyttjande av klenvirke

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2002